pillbase.ru

CRYSVITA

Active substance: Burosumab

INJECTION · BUROSUMAB 10 mg/mL

United StatesActive

Marketing holder: Kyowa Kirin, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Crysvita
    burosumab
    EMEA/H/C/004275
    Kyowa Kirin Holdings B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-9016-71f3-bae7-7a9309056702,01a12095-c12f-776a-8bce-be56ca9efb83,01a12098-679f-725f-8113-add72c903861;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
42747-102
Registration status
Active
Dispensing
Prescription only
Route
SUBCUTANEOUS
Sources
  • product · openFDA NDC · 42747-102 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 42747-102 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 42747-102 · Verified 2026-10-09 · open in source